BioWorld MedTech

Aug. 29, 2012

Aesthetics is going strong while orthopedics struggles

German valve registry reveals real-world TAVI experience

MUNICH, Germany — Minimally invasive aortic valve replacement accounted for 28% of procedures in Germany in 2011, the year following approval of the procedure for reimbursement. Read More

PROTECT trial vindicates DES for long-term benefits

GE Healthcare's Discovery well suited for Hybrid OR

Medtronic reports results from Symplicity HTN-2 trial

Deals roundup: MM to acquire Ascender for undisclosed amount

Court Report: Medtronic expands patent lawsuit against Nuvasive

Med-Tech Notes

Agreements/contracts: PerkinElmer works with Mass Gen on sequencing

HIT roundup: EHNAC set to discuss PHI protection in upcoming webinar

Financings roundup: Nextremity closes $6.6M; opens first preferred round

People in the News

Product Briefs

Medgenics board member Brukardt dies at age 66

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...